Teva Pharmaceutical announces Q3 2026 financial results presentation scheduled for early November
Executive summary: Teva Pharmaceutical Industries Ltd. announced that it will host a conference call to discuss its third-quarter 2026 financial results on November 3, 2026, at 8 a.m. ET. The upcoming disclosure is a critical event for stakeholders to assess the company's financial health and operational performance for the third quarter.
Who is involved: Teva Pharmaceutical Industries Ltd. (NYSE: TEVA, TASE: TEVA).
Likely next: The release of the Q3 2026 financial results and the subsequent investor conference call on November 3.
Teva Pharmaceutical Industries has scheduled a conference call to disclose its financial performance for the third quarter of 2026. The announcement follows the release of an aide memoire regarding the same period. This scheduled update serves as a key milestone for investors monitoring the company's quarterly fiscal trajectory.
What's next — scenarios
Base: Results aligned with market expectations (60%)
Stock stability or marginal movement following the November 3 call.
- Financial data release on November 3
Upside: Stronger than expected margins (25%)
Positive momentum for TEVA stock and increased investor confidence.
- Reported revenue exceeding analyst consensus
Downside: Missed earnings targets (15%)
Potential volatility and sell-off in TEVA shares.
- Lower than expected Q3 revenue or net income
What to watch
- November 3, 2026: Q3 2026 financial results release
- November 3, 2026, 8:00 AM ET: Teva conference call
Timeline
- — Teva to Host Conference Call to Discuss Third Quarter 2026 Financial Results on November 3, 2026 at 8 a.m. ET (GlobeNewswire)
- — Teva Releases Q3 2026 Aide Memoire (GlobeNewswire)
Analysis — what this means
Likely next events
- Teva Q3 2026 results release and call on November 3, 2026
Sectors affected
- Pharmaceuticals
- Healthcare